You are here

COVID-19 Drug Discovery and Pandemic Preparedness

A new STEM CELLS Translational Medicine article from Sally Esmail and Wayne R. Danter (123Genetix, London, Ontario, Canada) describes a rapid screening technology for drug discovery and repurposing in the context of SARS‐CoV‐2/COVID-19. The DeepNEU induced pluripotent stem-cell-based platform can create and validate computer simulations of artificial lung cells infected with SARS‐CoV‐2 to enable the rapid identification of antiviral therapeutic targets and drug repurposing and allow us to prepare for pandemic situations.